References:
1. Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N,
Howenstine M, McColley SA, Rock M, Rosenfeld M, et al. Diagnosis of
Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis
Foundation. J Pediatr 2017;181:S4-S15.e1.
2. Farrell MH, La Pean Kirschner A, Tluczek A, Farrell PM. Experience
with Parent Follow-Up for Communication Outcomes after Newborn Screening
Identifies Carrier Status. J Pediatr 2020;224:37-43.e2.
3. Farrell MH, Sims AM, La Pean Kirschner A, Farrell PM, Tarini BA.
Vulnerable Child Syndrome and Newborn Screening Carrier Results for
Cystic Fibrosis or Sickle Cell. J Pediatr 2020;224:44-50.e1.
4. Çolak Y, Nordestgaard BG, Afzal S. Morbidity and mortality in
carriers of the cystic fibrosis mutation CFTR Phe508del in the general
population. Eur Respir J 2020;56(3):1–12.
5. Miller AC, Comellas AP, Hornick DB, Stoltz DA, Cavanaugh JE, Gerke
AK, Welsh MJ, Zabner J, Polgreen PM. Cystic fibrosis carriers are at
increased risk for a wide range of cystic fibrosis-related conditions.
Proc Natl Acad Sci U S A 2020;117(3):1621–1627.
6. Martin C, Burgel PR. Carriers of a single CFTR mutation are
asymptomatic: An evolving dogma? Eur Respir J 2020;56(3):10–13.
7. Schlüter DK, Southern KW, Dryden C, Diggle P, Taylor-Robinson D.
Impact of newborn screening on outcomes and social inequalities in
cystic fibrosis: A UK CF registry-based study. Thorax 2019:123–131.
8. Ďurč P, Foret F, Homola L, Malá M, Pokojová E, Vinohradská H, Dastych
M, Krausová D, Nagy D, Bede O, et al. Skin wipe test: A simple,
inexpensive, and fast approach in the diagnosis of cystic fibrosis.
Pediatr Pulmonol 2020;55(7):1653–1660.
9. McColley SA, Elbert A, Wu R, Ren CL, Sontag MK, LeGrys VA. Quantity
not sufficient rates and delays in sweat testing in US infants with
cystic fibrosis. Pediatr Pulmonol 2020;55(11):3053–3056.
10. Munck A, Bourmaud A, Bellon G, Picq P, Farrell PM. Phenotype of
children with inconclusive cystic fibrosis diagnosis after newborn
screening. Pediatr Pulmonol 2020;55(4):918–928.
11. Rock MJ. How to define CRMS/CFSPID conversion to CF. Pediatr
Pulmonol 2020;55(7):1548–1549.
12. Terlizzi V, Mergni G, Centrone C, Festini F, Taccetti G. Trend of
sweat chloride values in a cohort of patients carrying CFTR mutations of
varying clinical consequence: Is there a risk of increasing sweat
chloride over time? Pediatr Pulmonol 2020;55(5):1089–1093.
13. Quittner AL, Abbott J, Georgiopoulos AM, Goldbeck L, Smith B,
Hempstead SE, Marshall B, Sabadosa KA, Elborn S, Boyle M, et al.
International Committee on Mental Health in Cystic Fibrosis: Cystic
Fibrosis Foundation and European Cystic Fibrosis Society consensus
statements for screening and treating depression and anxiety. Thorax
2016;71(1):26–34.
14. Liu FF, Lew A, Andes E, McNamara S, Cassidy J, Whitmore S, Plunkett
R, Ong T. Implementation strategies for depression and anxiety screening
in a pediatric cystic fibrosis center: A quality improvement project.
Pediatr Pulmonol 2020;55(12):3328–3336.
15. Quittner AL, Abbott J, Hussain S, Ong T, Uluer A, Hempstead S, Lomas
P, Smith B. Integration of mental health screening and treatment into
cystic fibrosis clinics: Evaluation of initial implementation in 84
programs across the United States. Pediatr Pulmonol
2020;55(11):2995–3004.
16. Borschuk AP, Molitor S, Everhart RS, Siracusa C, Filigno SS.
Executive functioning in pediatric cystic fibrosis: A preliminary study
and conceptual model. Pediatr Pulmonol 2020;55(4):939–947.
17. Lowery EM, Afshar M, West N, Kovacs EJ, Smith B, Joyce C.
Self-reported alcohol use in the cystic fibrosis community. J Cyst
Fibros 2020;19(1):84–90.
18. Toprak D, Nay L, McNamara S, Rosenberg AR, Rosenfeld M, Yi-Frazier
JP. Resilience in adolescents and young adults with cystic fibrosis: A
pilot feasibility study of the promoting resilience in stress
management intervention. Pediatr Pulmonol 2020;55(3):638–645.
19. Amerio A, Sibilla F, Pescini R, Ciprandi R, Casciaro R, Grimaldi
Filioli P, Porcelli C, Odone A, Costanza A, Aguglia A, et al. Mental
health and cystic fibrosis: Time to move from secondary prevention to
predictive medicine. Pediatr Pulmonol 2020;55(9):2204–2206.
20. Hente E, Sears R, Cotton S, Pallerla H, Siracusa C, Filigno SS, Boat
T. A Pilot Study of Mindfulness-Based Cognitive Therapy to Improve
Well-Being for Health Professionals Providing Chronic Disease Care. J
Pediatr 2020;224:87-93.e1.
21. Olesen H V., Drevinek P, Gulmans VA, Hatziagorou E, Jung A,
Mei-Zahav M, Stojnic N, Thomas M, Zolin A. Cystic fibrosis related
diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al.
J Cyst Fibros 2020;19(2):321–327.
22. Prentice BJ, Ooi CY, Verge CF, Hameed S, Widger J. Glucose
abnormalities detected by continuous glucose monitoring are common in
young children with Cystic Fibrosis. J Cyst Fibros 2020;19(5):700–703.
23. Chan C. Cystic fibrosis related diabetes: Revisiting the OGTT and
alternative screening tests. J Cyst Fibros 2020;19(5):671–672.
24. Kilberg MJ, Sheikh S, Stefanovski D, Kubrak C, De Leon DD,
Hadjiliadis D, Rubenstein RC, Rickels MR, Kelly A. Dysregulated insulin
in pancreatic insufficient cystic fibrosis with post-prandial
hypoglycemia. J Cyst Fibros 2020;19(2):310–315.
25. Armaghanian N, Hetherington J, Parameswaran V, Chua EL, Markovic TP,
Brand-Miller J, Steinbeck K. Hypoglycemia in cystic fibrosis during an
extended oral glucose tolerance test. Pediatr Pulmonol
2020;55(12):3391–3399.
26. Sherwood JS, Jafri RZ, Balliro CA, Zheng H, El-Khatib FH, Damiano
ER, Russell SJ, Putman MS. Automated glycemic control with the bionic
pancreas in cystic fibrosis-related diabetes: A pilot study. J Cyst
Fibros 2020;19(1):159–161.
27. Gur M, Bar-Yoseph R, Diab G, Hanna M, Rozen G, Daud F, Keidar Z,
Toukan Y, Masarweh K, Nir V, et al. Understanding the interplay between
factors that influence bone mineral density in CF. Pediatr Pulmonol
2020;55(10):2667–2673.
28. Trandel ET, Pilewski JM, Dellon EP, Jeong K, Yabes JG, Moreines LT,
Arnold RM, Hoydich ZP, Kavalieratos D. Prevalence of unmet palliative
care needs in adults with cystic fibrosis. J Cyst Fibros
2020;19(3):394–401.
29. Trandel ET, Kavalieratos D, Basile M, Hobler MR, Georgiopoulos AM,
Chen E, Goggin JL, Goss CH, Hempstead SE, Faro A, et al. Palliative care
skills in CF: Perspectives of adults with CF, caregivers, and CF care
team members. Pediatr Pulmonol 2020;55(8):2017–2024.
30. Waldman E, Quinn M. Palliative care and cystic fibrosis:
Opportunities for growth. Pediatr Pulmonol 2020;55(9):2179–2180.
31. Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel
PR, Tullis E, Castaños C, Castellani C, et al. The future of cystic
fibrosis care: a global perspective. Lancet Respir Med
2020;8(1):65–124.
32. Dogru D, Çakır E, Eyüboğlu TŞ, Pekcan S, Özçelik U. Cystic fibrosis
in Turkey. Lancet Respir Med 2020;8(4):e17.
33. Shi R, Wang X, Lu X, Zhu Z, Xu Q, Wang H, Song L, Zhu C. A
systematic review of the clinical and genetic characteristics of Chinese
patients with cystic fibrosis. Pediatr Pulmonol 2020;55(11):3005–3011.
34. Dogru D, Çakır E, Şişmanlar T, Çobanoğlu N, Pekcan S, Cinel G,
Yalçın E, Kiper N, Şen V, S. Şen H, et al. Cystic fibrosis in Turkey:
First data from the national registry. Pediatr Pulmonol
2020;55(2):541–548.
35. Shen Y, Tang X, Liu J, Li H, Zhao S. Pseudo-Bartter syndrome in
Chinese children with cystic fibrosis: Clinical features and genotypic
findings. Pediatr Pulmonol 2020;55(11):3021–3029.
36. Sismanlar Eyuboglu T, Dogru D, Çakır E, Cobanoglu N, Pekcan S, Cinel
G, Yalçın E, Kiper N, Sen V, Selimoglu Sen H, et al. Clinical features
and accompanying findings of Pseudo-Bartter Syndrome in cystic fibrosis.
Pediatr Pulmonol 2020;55(8):2011–2016.
37. Owusu SK, Morrow BM, White D, Klugman S, Vanker A, Gray D, Zampoli
M. Cystic fibrosis in black African children in South Africa: a case
control study. J Cyst Fibros 2019;19:540–545.
38. Fitzgerald C, Linnane B, George S, Ni Chroinin M, Mullane D, Herzig
M, Greally P, Elnazir B, Healy F, Mc Nally P, et al. Neonatal screening
programme for CF: Results from the Irish Comparative Outcomes Study
(ICOS). Pediatr Pulmonol 2020;55(9):2323–2329.
39. M S, A K, M D. First case of cystic fibrosis in Greenland –
diagnosed by neonatal screening. J Cyst Fibros 2020;19(3):e14–e15.
40. Pasterkamp H, Menzies KJ, Bayomi DJ. Cystic fibrosis in Canadian
Hutterites. Pediatr Pulmonol 2020;55(2):526–532.
41. Zybert K, Wozniacki L, Tomaszewska-Sobczyńska A, Wertheim-Tysarowska
K, Czerska K, Ołtarzewski M, Sands D. Clinical characteristics of rare
CFTR mutations causing cystic fibrosis in Polish population. Pediatr
Pulmonol 2020;55(8):2097–2107.
42. Rowbotham NJ, Smith S, Leighton PA, Rayner OC, Gathercole K, Elliott
ZC, Nash EF, Daniels T, Duff AJA, Collins S, et al. The top 10 research
priorities in cystic fibrosis developed by a partnership between people
with CF and healthcare providers. Thorax 2018;73(4):388–390.
43. Hollin I, Donaldson S, Roman C, Aliaj E, Riva D, Boyle M, Borowitz
D. Beyond the expected: Identifying broad research priorities of
researchers and the cystic fibrosis community. J Cyst Fibros
2019;18(3):375–377.
44. Davies G, Rowbotham NJ, Smith S, Elliot ZC, Gathercole K, Rayner O,
Leighton PA, Herbert S, Duff AJ, Chandran S, et al. Characterising
burden of treatment in cystic fibrosis to identify priority areas for
clinical trials. J Cyst Fibros 2020;19(3):499–502.
45. Cooley L, Hudson J, Potter E, Raymond KF, George C, Georgiopoulos
AM. Clinical communication preferences in cystic fibrosis and strategies
to optimize care. Pediatr Pulmonol 2020;55(4):948–958.
46. Haywood KB, Goralski JL. The specialist as primary care provider in
CF. J Cyst Fibros 2020;19(5):844–845.
47. Douglas TA, Pooley JA, Shields L, Stick SM, Branch-Smith C. Early
disease surveillance in young children with cystic fibrosis: A
qualitative analysis of parent experiences. J Cyst Fibros
2020;(xxxx):5–9.
48. Oates GR, Harris WT, Gutierrez HH, Mims C, Rutland SB, Ott C,
Niranjan SJ, Scarinci IC, Walley SC. Tobacco smoke exposure in pediatric
cystic fibrosis: A qualitative study of clinician and caregiver
perspectives on smoking cessation. Pediatr Pulmonol
2020;55(9):2330–2340.
49. Zobell JT, Moss J, Heuser SM, Asfour F. Impact of pharmacy
technicians as part of an integrated health-system pharmacy team on
improvement of medication access in the care of cystic fibrosis
patients. Pediatr Pulmonol 2020;55(12):3351–3357.
50. Reynaud Q, Rousset Jablonski C, Poupon-Bourdy S, Denis A, Rabilloud
M, Lemonnier L, Nove-Josserand R, Durupt S, Touzet S, Durieu I.
Pregnancy outcome in women with cystic fibrosis and poor pulmonary
function. J Cyst Fibros 2020;19(1):80–83.
51. Vijayasingam A, Frost E, Wilkins J, Gillen L, Premachandra P,
McLaren K, Gilmartin D, Picinali L, Vidal-Diez A, Borsci S, et al.
Tablet and web-based audiometry to screen for hearing loss in adults
with cystic fibrosis. Thorax 2020;75(8):632–639.